PharmaOnco™ MAGE A10-Specific T cells (CAT#: ITS-0423-LX12)

Creative Biolabs offers MAGE A10-Specific T cells for immunity reaserch.

MAGE A10-Specific T cells refer to T cells that are specifically engineered to recognize and target cells expressing the MAGE A10 protein. MAGE A10 is a tumor antigen that is commonly overexpressed in various cancers, making it a promising target for cancer immunotherapy. By engineering T cells to target MAGE A10, these cells can effectively seek out and destroy cancer cells expressing this antigen, leading to targeted and precise treatment of MAGE A10-positive cancers.

MAGE A10-specific T cells are a type of immune cell that specifically recognizes and targets cells that express the MAGE A10 protein. This protein is often found in cancer cells and can serve as a target for immune-based therapies, such as adoptive T cell transfer. By isolating and expanding MAGE A10-specific T cells from a patient's own immune system, researchers can potentially enhance the body's ability to fight against cancer cells that express this protein.

Human

T cell population

We recommend RPMI-1640 with 10% FBS media for our functional analysis, but that depends on the media used by customers for co-culturing experiments.

High quality;
High viability;
Widely applications.

With proper stimulation, they will survive for about 4-5 days.

MAGE A10